Causes of Complications in the Cardiovascular System in Patients with Covid-19
Keywords:
cardiovascular, thrombosis, COVID-19, prothrombin time, prothrombin index, APTT, INR, fibrinogen, thrombin time
Abstract
Although COVID-19 belongs to the respiratory viruses that affect the respiratory tract, more and more doctors are considering a new coronavirus infection as a disease that has a significant impact on the cardiovascular system.
When data were collected on the possible effects of COVID-19, scientists found that post-covid syndrome was more severe in patients than in viral infections.
References
1. Avula A., Nalleballe K., Narula N., Sapozhnikov S., Dandu V., Toom S., Glaser A., Elsayegh D. COVID-19 as a stroke. Brain Behav. Immun. 2020; 87: 115–119. DOI: 10.1016 / j.bbi.2020.04.077
2. Leisman D.E., Deutschman C.S., Legrand M. Exposure to COVID-19 in ICU: vascular dysfunction, thrombosis, and unregulated inflammation. Resuscitation medicine. 2020; 46 (6): 1105-1108. DOI: 10.1007 / s00134- 020-06059-6
3. Hoffmann M., Kleine-Weber H., Shreder S., Krüger N., Herrler T., Erichsen S., Sheergens TS, Herrler G., Vu NH, Nitsche A., Müller MA, Drosten C., Pyulman S. The production of SARS-CoV-2 cells is dependent on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020; 181 (2): 271-280.e8. DOI: 10.1016 / j. cell.2020.02.052
4. Temporary instructions. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 7 (06.03.2020). Moscow, 2020.
5. Eremenko A.A. Drug treatment of acute heart failure: what and what awaits us // Bulletin of Anesthesiology and Intensive Care. - 2020. - T. 17, No 2. - P. 29‒37. DOI: 10.21292 / 2078-5658-2020-17-2-29-37.
6. Kozlov IA, Tyurin IN Septic cardiopathy: controversial issues and prospects // Bulletin of Anesthesiology and Intensive Care. - 2020. - T. 17, No 2. - S. 49‒58. DOI: 10.21292 / 2078-5658-2020-17-2-49-58.
7. Official website of the American College of Cardiology. www.acc.org/latest-in cardiology / articles / 2020/03/17/08/59 / hfsa-acc-aha-statement-solves the problems associated with the reuse of raas-antagonists in kovid-19.
2. Leisman D.E., Deutschman C.S., Legrand M. Exposure to COVID-19 in ICU: vascular dysfunction, thrombosis, and unregulated inflammation. Resuscitation medicine. 2020; 46 (6): 1105-1108. DOI: 10.1007 / s00134- 020-06059-6
3. Hoffmann M., Kleine-Weber H., Shreder S., Krüger N., Herrler T., Erichsen S., Sheergens TS, Herrler G., Vu NH, Nitsche A., Müller MA, Drosten C., Pyulman S. The production of SARS-CoV-2 cells is dependent on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020; 181 (2): 271-280.e8. DOI: 10.1016 / j. cell.2020.02.052
4. Temporary instructions. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 7 (06.03.2020). Moscow, 2020.
5. Eremenko A.A. Drug treatment of acute heart failure: what and what awaits us // Bulletin of Anesthesiology and Intensive Care. - 2020. - T. 17, No 2. - P. 29‒37. DOI: 10.21292 / 2078-5658-2020-17-2-29-37.
6. Kozlov IA, Tyurin IN Septic cardiopathy: controversial issues and prospects // Bulletin of Anesthesiology and Intensive Care. - 2020. - T. 17, No 2. - S. 49‒58. DOI: 10.21292 / 2078-5658-2020-17-2-49-58.
7. Official website of the American College of Cardiology. www.acc.org/latest-in cardiology / articles / 2020/03/17/08/59 / hfsa-acc-aha-statement-solves the problems associated with the reuse of raas-antagonists in kovid-19.
Published
2021-12-27
How to Cite
Baxadirovna, A. S., & qizi, Q. D. S. (2021). Causes of Complications in the Cardiovascular System in Patients with Covid-19. Central Asian Journal of Medical and Natural Science, 2(6), 460-463. https://doi.org/10.17605/cajmns.v2i6.535
Section
Articles
